Beam Therapeutics (BEAM)
(Delayed Data from NSDQ)
$32.17 USD
+2.36 (7.92%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $32.14 -0.03 (-0.09%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -1.13 |
EPS Last Quarter | -1.21 |
Last EPS Surprise | 16.55% |
ABR | 1.88 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.68 |
Next Year | -4.66 |
EPS (TTM) | -1.78 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 14.12M | 15.47M | 56.37M | 59.00M |
# of Estimates | 5 | 5 | 6 | 5 |
High Estimate | 24.20M | 24.20M | 80.00M | 80.00M |
Low Estimate | 5.00M | 5.00M | 22.40M | 20.00M |
Year ago Sales | 20.12M | 17.19M | 377.71M | 56.37M |
Year over Year Growth Est. | -29.82% | -9.99% | -85.08% | 4.67% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.13 | -1.15 | -4.68 | -4.66 |
# of Estimates | 7 | 6 | 8 | 6 |
Most Recent Consensus | -1.01 | -1.23 | -4.90 | -4.75 |
High Estimate | -0.91 | -0.88 | -3.87 | -3.30 |
Low Estimate | -1.28 | -1.32 | -4.95 | -5.25 |
Year ago EPS | -1.08 | -1.22 | -1.72 | -4.68 |
Year over Year Growth Est. | -4.63% | 5.74% | -172.09% | 0.50% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.13 | -1.15 | -4.68 | -4.66 |
7 Days Ago | -1.13 | -1.15 | -4.68 | -4.66 |
30 Days Ago | -1.13 | -1.15 | -4.68 | -4.66 |
60 Days Ago | -1.13 | -1.15 | -4.68 | -4.66 |
90 Days Ago | -1.44 | -1.41 | -5.53 | -5.04 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.13 | -1.15 | -4.68 | -4.66 |
Zacks Consensus Estimate | -1.13 | -1.15 | -4.68 | -4.66 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.21 | 1.73 | -1.22 | -1.08 | NA |
Estimate | -1.45 | -1.15 | -1.37 | -1.38 | NA |
Difference | 0.24 | 2.88 | 0.15 | 0.30 | 0.89 |
Surprise | 16.55% | 250.43% | 10.95% | 21.74% | 74.92% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more